BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17216915)

  • 1. [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors].
    Puccio D; Montalto S; Valerio MC; Ventimiglia A; Caronia A; Novo S
    G Ital Cardiol (Rome); 2006 Nov; 7(11):739-46. PubMed ID: 17216915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin.
    Kalus JS; Caron MF
    Expert Opin Investig Drugs; 2004 May; 13(5):465-77. PubMed ID: 15155122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct thrombin inhibitors: pharmacology and clinical relevance.
    Kam PC; Kaur N; Thong CL
    Anaesthesia; 2005 Jun; 60(6):565-74. PubMed ID: 15918828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Direct thrombin antagonists].
    Lankes W; Fleischer K; Gulba DC
    Herz; 2001 Apr; 26 Suppl 1():46-52. PubMed ID: 11349627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical potential of oral direct thrombin inhibitors in the prevention and treatment of venous thromboembolism.
    Agnelli G
    Drugs; 2004; 64 Suppl 1():47-52. PubMed ID: 15586627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anticoagulants - direct thrombin inhibitors].
    Brand B; Graf L
    Ther Umsch; 2012 Nov; 69(11):643-9. PubMed ID: 23117667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
    Meddahi S; Samama MM
    J Mal Vasc; 2011 Feb; 36(1):24-32. PubMed ID: 21239127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
    Gurm HS; Bhatt DL
    Am Heart J; 2005 Jan; 149(1 Suppl):S43-53. PubMed ID: 15644793
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
    Bates SM; Weitz JI
    Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant therapy for percutaneous coronary intervention.
    Rao SV; Ohman EM
    Circ Cardiovasc Interv; 2010 Feb; 3(1):80-8. PubMed ID: 20160186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment and prevention of venous thromboembolic events: present and future antithrombotic agents].
    Drouet L
    Bull Acad Natl Med; 2003; 187(1):85-96; discussion 96-7. PubMed ID: 14556456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ximelagatran: a new oral anticoagulant.
    Hrebickova L; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New trends in anticoagulant treatments.
    Pengo V
    Lupus; 2005; 14(9):789-93. PubMed ID: 16218489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin: a new approach to anticoagulation.
    Nawarskas JJ; Anderson JR
    Heart Dis; 2001; 3(2):131-7. PubMed ID: 11975781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.
    McCullough PA; Dorrell KA; Sandberg KR; Yerkey MW
    Rev Cardiovasc Med; 2004; 5(2):99-103. PubMed ID: 15184843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct thrombin inhibitors.
    Lee CJ; Ansell JE
    Br J Clin Pharmacol; 2011 Oct; 72(4):581-92. PubMed ID: 21241354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational success stories: development of direct thrombin inhibitors.
    Coppens M; Eikelboom JW; Gustafsson D; Weitz JI; Hirsh J
    Circ Res; 2012 Sep; 111(7):920-9. PubMed ID: 22982873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs].
    Falciani M; Imberti D; Prisco D
    Recenti Prog Med; 2005 Apr; 96(4):196-204. PubMed ID: 15932039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.